RECRUITING

Connect-Home: Alzheimer's Disease and Related Dementias

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Official Title

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Quick Facts

Study Start:2025-04-04
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06840587

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to speak English
  2. * Goal of discharge to home, assisted living, or long-term care
  3. * Diagnosis of dementia
  4. * Having a caregiver willing to participate
  5. * Ability to speak English
  6. * Legally authorized representative (LAR) who also provides support for the person with ADRD
  7. * Location within 120 miles of UNC-Chapel Hill
  8. * Admission of at least 75 SNF patients per year
  1. * Planned hospital readmission for procedures or treatments within 30 days post enrollment.
  2. * LAR is a court-appointed guardian.

Contacts and Locations

Study Contact

Molly Lynch, MS
CONTACT
9198438874
molly_lynch@unc.edu
Kathryn Wessell, MPH
CONTACT
919-966-2939
kwessell@email.unc.edu

Principal Investigator

Mark Toles, PhD, RN
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: University of North Carolina, Chapel Hill

  • Mark Toles, PhD, RN, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-04
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2025-04-04
Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Alzheimer Disease
  • Dementia